Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -141.31%-10.16M | 407.47%102.23M | 617.72%75.8M | 180.95%70.41M | 506.63%122.51M | -249.45%-4.21M | -278.52%-33.25M | 71.23%-14.64M | -273.68%-86.98M | -162.53%-30.13M |
| Net profit before non-cash adjustment | -0.90%72.6M | -19.79%59.97M | 250.06%67.12M | 45.70%275.85M | -0.08%108.65M | 306.41%73.26M | 151.20%74.76M | -41.54%19.17M | 62.42%189.32M | 392.38%108.73M |
| Total adjustment of non-cash items | 31.15%27.67M | 831.43%28.76M | 77.13%30.65M | 139.88%27.79M | 91.82%-6.68M | 100.71%21.1M | -637.89%-3.93M | 2,333.90%17.31M | -99.87%-69.7M | -1,219.44%-81.65M |
| -Depreciation and amortization | 6.70%19.28M | 35.87%21.36M | 63.27%18.14M | 66.79%63.3M | 73.88%18.41M | 109.69%18.07M | 68.85%15.72M | 17.67%11.11M | -2.55%37.95M | -7.12%10.59M |
| -Reversal of impairment losses recognized in profit and loss | -41.31%1.5M | -15.92%1.13M | -100.17%-3K | -143.45%-10.7M | -197.77%-16.33M | 58.22%2.55M | -69.77%1.34M | -7.13%1.75M | 42.77%24.62M | 33.32%16.7M |
| -Assets reserve and write-off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --650K | ---- |
| -Share of associates | -108.29%-1.47M | 85.85%-3.21M | -238.14%-8.2M | 79.34%-13.71M | 74.84%-6.38M | 275.93%17.75M | -19.12%-22.66M | 79.64%-2.43M | -112.66%-66.37M | -401.12%-25.35M |
| -Disposal profit | 46.68%-17.73M | 20.65%-12.62M | 101.33%78K | -380.68%-84.13M | -195.76%-29.12M | -3,524.72%-33.25M | -522.83%-15.91M | 3.67%-5.85M | 79.10%-17.5M | 70.27%-9.84M |
| -Net exchange gains and losses | 104.12%129K | -620.69%-151K | 80.77%-5K | -1,875.23%-4.23M | -345.54%-1.1M | -824.54%-3.13M | 103.57%29K | 90.78%-26K | -157.07%-214K | -76.69%448K |
| -Other non-cash items | 35.82%25.97M | 26.85%22.25M | 61.87%20.65M | 258.20%77.25M | 137.19%27.84M | 113.19%19.12M | 87.05%17.54M | 66.49%12.76M | -307.50%-48.83M | -1,319.90%-74.84M |
| Changes in working capital | -12.03%-110.43M | 112.97%13.5M | 57.01%-21.97M | -12.89%-233.22M | 135.91%20.54M | -283.21%-98.57M | -164.98%-104.08M | 39.43%-51.12M | -553.59%-206.6M | -404.23%-57.21M |
| -Change in receivables | 3.51%-65.48M | 244.22%22.61M | -6.22%64.14M | 2.97%-129.94M | 3.00%-114.8M | -519.78%-67.86M | -26.21%-15.67M | 776.62%68.39M | -656.56%-133.92M | -522.41%-118.35M |
| -Change in inventory | -665.01%-27.65M | 316.82%97.07M | 85.02%-4.32M | 29.36%-90.66M | 76.02%-21.93M | 902.66%4.89M | -358.56%-44.77M | -4.38%-28.86M | -20.27%-128.35M | -5,315.57%-91.43M |
| -Change in payables | -272.91%-94.91M | 310.95%119.86M | 17.13%-65.53M | 1.19%165.76M | -13.72%160.79M | 1,472.33%54.89M | 538.88%29.17M | -158.46%-79.08M | 22.16%163.81M | 132.50%186.35M |
| -Changes in other current assets | 185.75%77.6M | -210.47%-226.03M | -40.45%-16.27M | -64.96%-178.39M | 89.59%-3.52M | -382.58%-90.49M | -236.10%-72.8M | 65.89%-11.58M | -161.94%-108.14M | 23.38%-33.78M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 30.63%-20.77M | -13.46%-19.57M | -35.42%-19.4M | -66.90%-78.51M | 7.64%-17M | -192.19%-29.94M | -75.84%-17.25M | -66.88%-14.32M | -41.11%-47.04M | -58.18%-18.4M |
| Interest received (cash flow from operating activities) | -16.86%2.87M | 54.55%1.53M | 39.31%1.77M | 201.31%10.37M | 462.68%4.66M | 172.06%3.45M | 132.94%990K | 38.11%1.27M | 7.60%3.44M | -49.76%828K |
| Tax refund paid | -11.63%-23.62M | -10.57%-17.98M | -116.84%-13.87M | -306.40%-62.29M | -114.19%-18.48M | -654.30%-21.16M | -641.83%-16.26M | -275.46%-6.39M | -5.86%-15.33M | -58.40%-8.63M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 0.35%-51.68M | 200.68%66.22M | 230.00%44.31M | 58.86%-60.02M | 262.79%91.7M | -478.27%-51.87M | -223.04%-65.77M | 43.43%-34.09M | -2,769.30%-145.9M | -271.99%-56.33M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -79.26%3.55M | -310.49%-45.21M | -13.04%-11.61M | -31.45%-36.8M | -1,890.13%-32.66M | 229.72%17.13M | -34.38%-11.01M | -107.23%-10.27M | -55.17%-28M | 70.85%-1.64M |
| Net business purchase and sale | 136.25%18.77M | 20.86%-78.88M | 134.88%13.61M | -30.14%-169.24M | 122.21%21.24M | 26.53%-51.77M | -364.31%-99.68M | -2,237.01%-39.03M | -2,097.31%-130.05M | -223.85%-95.63M |
| Net investment property transactions | ---- | ---- | ---- | 1,530.22%11.33M | ---- | ---- | ---- | ---- | -75.09%695K | ---- |
| Net investment product transactions | -60.17%55.37M | 114.41%2.1M | -53.92%19.62M | 345.53%163.35M | 88.54%-3.66M | 1,048.34%139.01M | 26.29%-14.57M | 258.11%42.57M | -628.05%-66.53M | -249.56%-31.94M |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Dividends received (cash flow from investment activities) | --0 | --0 | --1.06M | 193.41%2.05M | --2.05M | --0 | --0 | --0 | --698K | ---- |
| Net changes in other investments | -89.95%4.29M | --30.09M | --25.95M | -51.25%46.1M | -98.65%600K | -12.58%42.7M | ---- | ---- | 932.25%94.55M | 2,847.75%44.45M |
| Investing cash flow | -44.26%81.98M | 24.96%-91.9M | 823.51%48.63M | 113.05%16.78M | 98.68%-1.1M | 747.38%147.07M | -1,212.19%-122.46M | 79.97%-6.72M | -1,374.90%-128.63M | -224.91%-83.37M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 0.96%-33.77M | -38.07%149.14M | -76.24%15.71M | 8.77%198.92M | -155.44%-73.9M | -354.26%-34.1M | 479.63%240.8M | 1,331.92%66.12M | 173.70%182.88M | 300.00%133.3M |
| Net common stock issuance | -1,595.09%-212.66M | ---- | ---- | --29.87M | --15.64M | --14.22M | ---- | ---- | --0 | --0 |
| Increase or decrease of lease financing | -321.57%-14.08M | 314.86%10.6M | 63.96%-829K | -108.05%-18.24M | -110.26%-17.36M | 1,413.10%6.36M | -10,397.87%-4.93M | -160.48%-2.3M | -8.96%-8.77M | -70.33%-8.26M |
| Cash dividends for minorities | --0 | 66.57%-7.61M | ---22.09M | ---36.13M | ---13.36M | --0 | ---22.77M | --0 | --0 | --0 |
| Net other fund-raising expenses | 589.30%331.25M | -272.45%-214.76M | -190.52%-92.74M | -24.26%82.15M | 9.33%57.23M | -656.64%-67.7M | 646.45%124.53M | -147.83%-31.92M | 11,699.89%108.46M | 570.11%52.35M |
| Financing cash flow | 187.09%70.74M | -71.62%95.83M | -413.34%-99.94M | -9.21%256.56M | -117.90%-31.75M | -412.46%-81.22M | 1,704.74%337.63M | -47.27%31.9M | 603.87%282.58M | 344.57%177.39M |
| Net cash flow | ||||||||||
| Beginning cash position | 49.10%397.37M | 170.57%320.2M | 161.90%335.09M | 7.52%125.28M | 211.01%272.77M | 185.95%266.52M | 41.91%118.34M | 9.80%127.95M | 46.99%116.52M | -2.29%87.7M |
| Current changes in cash | 622.26%101.03M | -53.05%70.15M | 21.39%-7M | 2,551.01%213.33M | 56.12%58.85M | 345.66%13.99M | 1,496.02%149.4M | 73.25%-8.91M | -78.19%8.05M | 39.79%37.69M |
| Effect of exchange rate changes | 85.68%-1.11M | 672.13%7.02M | -1,036.46%-7.89M | -1,298.31%-8.51M | 1,105.22%1.16M | -4,091.24%-7.74M | -373.27%-1.23M | -481.32%-694K | 97.77%710K | 41.33%-115K |
| End cash Position | 82.31%497.29M | 49.10%397.37M | 170.57%320.2M | 163.49%330.1M | 163.49%330.1M | 211.01%272.77M | 185.95%266.52M | 41.91%118.34M | 7.52%125.28M | 7.52%125.28M |
| Free cash flow | 6.84%-65.07M | 127.32%21.05M | 168.32%30.96M | 26.63%-127.97M | 210.24%64.23M | -214.80%-69.85M | -169.07%-77.04M | 30.64%-45.31M | -1,135.86%-174.4M | -318.19%-58.26M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.